Neurogene Inc.NGNEEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Neurogene Inc. is a clinical-stage biotechnology company focused on developing adeno-associated virus (AAV)-based gene therapies for patients with rare, genetically driven neurological disorders that have significant unmet medical needs, with its primary operating markets spanning North America and Europe.